Literature DB >> 1819741

Induction of platelet-activating factor in mice by intravenous administration of a neutral fraction of bakers' yeast mannan.

T Mikami1, K Fukushi, M Ishitani, K Ishitani, S Suzuki, M Suzuki.   

Abstract

A neutral subfraction of mannan of bakers' yeast (WNM) was found to show a lethal effect in mice when administered intravenously. Symptoms caused by intravenous (i.v.) administration of WNM resembled those resulting from the administration of platelet-activating factor (PAF). CV-3988 and ONO-6240, selective PAF antagonists, prevented hypotension and death caused by the administration of WNM or PAF. A beta-adrenoceptor agonist was shown to prevent death caused by WNM, whereas propranolol increased the lethal activity of WNM. Intravenous administration of WNM into mice produced PAF in gall bladder fluid which was determined by platelet aggregation assay. The findings indicate that WNM is able to induce PAF in mice and that the resultant PAF may participate in the WNM-induced lethal activity observed in mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819741     DOI: 10.1007/BF02536576

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  25 in total

Review 1.  Carbohydrates as antigenic determinants of glycoproteins.

Authors:  T Feizi; R A Childs
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

2.  Structure of the carbohydrate units of IgE immunoglobulin. II. Sequence of the sialic acid-containing glycopeptides.

Authors:  J Baenziger; S Kornfeld; S Kochwa
Journal:  J Biol Chem       Date:  1974-03-25       Impact factor: 5.157

3.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

Authors:  M L Blank; F Snyder; L W Byers; B Brooks; E E Muirhead
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

4.  Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

Authors:  T W Doebber; M S Wu; J C Robbins; B M Choy; M N Chang; T Y Shen
Journal:  Biochem Biophys Res Commun       Date:  1985-03-29       Impact factor: 3.575

5.  Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF).

Authors:  D I Cargill; D S Cohen; R G Van Valen; J J Klimek; R P Levin
Journal:  Thromb Haemost       Date:  1983-06-28       Impact factor: 5.249

6.  Glucocorticoid protection against PAF-acether toxicity in mice.

Authors:  A Myers; E Ramey; P Ramwell
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

7.  The release of platelet-activating factor from human endothelial cells in culture.

Authors:  G Camussi; M Aglietta; F Malavasi; C Tetta; W Piacibello; F Sanavio; F Bussolino
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

8.  Effect of 1-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the rat.

Authors:  F Masugi; T Ogihara; A Otsuka; S Saeki; Y Kumahara
Journal:  Life Sci       Date:  1984-01-09       Impact factor: 5.037

9.  Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors.

Authors:  M Criscuoli; A Subissi
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

10.  Influence of yeast mannan on release of myeloperoxidase by human neutrophils: determination of structural features of mannan required for formation of myeloperoxidase-mannan-neutrophil complexes.

Authors:  C D Wright; J U Bowie; R D Nelson
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.